GEN Exclusives

More »

GEN News Highlights

More »
Apr 27, 2007

Wyeth Sells 10 Drugs for Almost $76.5M

  • Meda purchased 10 European on-market drugs from Wyeth for SEK 525 million, or approximately $76.49 million.

    Meda expects the products to add about SEK 160-170 million, or between $23 million and $25.41 million, in sales into its operation for the rest of 2007. It reports that the acquisition enhances its position in two of its most important markets, Italy and France. These countries account for about 60% of the acquired products' sales, according to the company.

    Meda states that the biggest product acquired through this deal is Seresta®, an anti-anxiety agent used for sleep disorders and various substance-withdrawal syndromes.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?